Back to all Current clinical trials
Back to all Current clinical trials
SWIFT - Do you have Moderate to Severely Active UC?
The goal of this study is to learn if GS-1427 is effective in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with GS-1427 with participants treated with placebo.
The primary objective of this study is to assess the efficacy of GS-1427, compared with placebo control, in achieving clinical response at Week 12.
What you need to know
Who can take part?
To participate, you must:
- Be 18-75 years of age
- Have UC diagnosis confirmed by endoscopy & histology
- Have had previous treatment for UC (confirm requirements with study team)
- Have test results within expected ranges
- Not have an additional condition that may impact your UC treatment
- Not have previously had Vedolizumab
- Not be taking any medications that may impact the results (study team will confirm)
- Not have surgery planned
- Not be pregnant or planning pregnancy
What is involved for me?
- Colonoscopy with biopsy
- Blood tests
- Daily diary completion
- Vital Signs
- ECG
- Questionnaires
- Eye exam
- Stool tests
- Urine tests
- Regular study appointments
